Skip to main content
main-content
Top

14-06-2019 | Rheumatoid arthritis | EULAR 2019 | Article

Expert commentary: Fenebrutinib in RA

Roy Fleischmann gives his thoughts on the phase IIb fenebrutinib findings in patients with biologic DMARD-refractory rheumatoid arthritis (1:09).

​​​​​​​

Related topics